Edward M. Kreps, MD

Acute Angiographic and Clinical Results of the NIR w/SOX Stent

08/01/2008

Roxana Mehran , MD;

Jeffrey W. Moses , MD;

Michael B. Collins , MD;

Edward M. Kreps , MD;

Milena Adamian , MD;

Issam Moussa , MD;

Yoshio Kobayashi , MD;

Kartik Desai , MD;

Gregg W. Stone , MD, FACC, FSCAI;

Martin B. Leon , MD;

George D. Dangas , MD, PhD;

Lower restenosis rates were shown in selected lesions with the first-generation Palmaz-Schatz stent when compared to conventional balloon angioplasty.1 However, because the Palmaz-Schatz stent and its delivery system were rigid, stent...

Lower restenosis rates were...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Treatment of Restenotic Drug-Eluting Stents: An Intravascular
Ultrasound Analysis

08/01/2008

Koichi Sano , MD, PhD;

Stephane G. Carlier , MD, PhD;

Emilia Solinas , MD;

Gregg W. Stone , MD, FACC, FSCAI;

Jie Qian , MD;

Gary S. Mintz , MD;

Eduardo Missel , MD;

Martin B. Leon , MD;

Roxana Mehran , MD;

Shoujie Shan , MD;

Alexandra J. Lansky , MD;

Jeffrey W. Moses , MD;

Theresa Franklin-Bond , MS, PA;

George D. Dangas , MD, PhD;

Giora Weisz , MD;

Paul Boland , BS;

Michael B. Collins , MD;

Nobuhiko Fujita , MD;

Edward M. Kreps , MD;

Issam Moussa , MD;

Jose de Ribamar Costa Jr., MD, PhD;

Sirolimus-eluting and paclitaxel-eluting stents decrease neointimal hyperplasia leading to a reduction, but not elimination, of in-stent restenosis.1–4 Because sirolimus and paclitaxel decrease neointimal hyperplasia, restenosis is dependent...

Sirolimus-eluting and...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

The Relative Effects of Abciximab and Tirofiban on Platelet Inhibition and C-Reactive Protein during Coronary Intervention

01/07/2010

Edward M. Kreps , MD;

Martin B. Leon , MD;

Alexandra J. Lansky , MD;

George D. Dangas , MD, PhD;

Adam J. Saltzman , MD;

Roxana Mehran , MD;

W. Craig Hooper , PhD;

Jeffrey W. Moses , MD;

Giora Weisz , MD;

Michael B. Collins , MD;

Gregg W. Stone , MD, FACC, FSCAI;

ABSTRACT: Background. We sought to compare the efficacy of tirofiban and abciximab on platelet inhibition as well as their effects of platelet inhibition on C-reactive protein levels during percutaneous coronary intervention (PCI). Methods....

ABSTRACT: Background. We sought...

01/07/2010

Journal of Invasive Cardiology